本文发表在 rolia.net/zh 相约加拿大网上社区枫下论坛
During Q2 Company D bought out a group of competing sales representatives (Party X) so that they would sell on behalf of said company. Party X has a strong reputation and market share (in the way of doctor/hospital relationships) in the region that they operate. Party X signed 2 contracts – the first is a buy-out agreement for a period of a minimum of 5 years (at which time Company D can terminate the agreement) and at 7 years (at which time Party X has the right to terminate the contract). If not cancelled the contract would continue on a yearly basis on the same terms and conditions. Company D had to make an upfront payment of $3m to Party X as a result of this contract. In addition the sales representatives earn commissions on sales made in line with Company D policy. The group and sales representatives were also required to sign a non-compete agreement barring them from further undertaking their work in the region under discussion for 1 year after termination of the agreement.
The intention is to capitalize the $3m as an intangible asset on the balance sheet and amortize over a period of 7 years. Please discuss the requirements to capitalize this intangible asset and what concerns/issues you would have? In addition please describe how you would perform an impairment review on this particular asset.
During Q1, Company A began the process of updating (rolling forward) their internal control process. Included in this process are the documentation, testing and audit-support processes. There are currently no dedicated resources (eg. internal audit) to the project and
you are responsible for managing the process and meeting the deadline of June 30. What steps would you take help ensure that this deadline is met? Would you involve the business (operations) in this process? If so, in what capacity would you involve them? What are the key hurdles to meeting the deadline and how would you clear them?
更多精彩文章及讨论，请光临枫下论坛. 网址: rolia.net/zh